This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Pediatric Neurology Briefs (Aug 1999)
Affiliations
Read online
The risk factors and methods of minimizing the occurrence of serious rash during treatment with lamotrigine (LTG) were evaluated by an international panel of experts and by review of published and unpublished reports.